Latest debt-to-equity ratio
Castle Biosciences Debt-to-equity ratio
Direct answer
Castle Biosciences's debt-to-equity ratio is 7.8%.
The verified market snapshot reports 7.8%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.
Get free Castle Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 7.8%
Explore related company data
View Castle Biosciences's market capitalizationView Castle Biosciences's price-to-book ratioView Castle Biosciences's return on equityView Castle Biosciences's dividend yieldView Castle Biosciences's 52-week price rangeView Castle Biosciences's revenue growthView Castle Biosciences's profit marginView all Castle Biosciences key metricsReturn to Castle Biosciences profile